ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 25.5 TWD -1.16% Market Closed
Market Cap: NT$20.2B

Operating Margin

5.2%
Current
Declining
by 4.5%
vs 3-y average of 9.7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.2%
=
Operating Income
NT$165.9m
/
Revenue
NT$3.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.2%
=
Operating Income
NT$165.9m
/
Revenue
NT$3.2B

Peer Comparison

Country Company Market Cap Operating
Margin
TW
ScinoPharm Taiwan Ltd
TWSE:1789
20.2B TWD
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Taiwan
Percentile
51th
Based on 1 045 companies
51th percentile
5.2%
Low
-21 347.1% — 0.7%
Typical Range
0.7% — 11.5%
High
11.5% — 698%
Distribution Statistics
Taiwan
Min -21 347.1%
30th Percentile 0.7%
Median 5%
70th Percentile 11.5%
Max 698%

ScinoPharm Taiwan Ltd
Glance View

Market Cap
20.2B TWD
Industry
Pharmaceuticals

ScinoPharm Taiwan Ltd. engages in the research, development, manufacturing, and sales of active pharmaceutical ingredients and injections. The company is headquartered in Tainan, Tainan. The company went IPO on 2010-10-29. The main products include active pharmaceutical ingredients, protein drugs, oligonucleotides, peptides, injection preparations, new small molecule drugs and other chemical raw materials. The firm is also engaged in the provision of consulting and biotechnology services for related products, the international trading of products, as well as the provision of customized full-process services such as chemical molecular component synthesis, process development and commercial mass production. The firm operates within the domestic market and to overseas markets, including the Americas, Europe, Australia and Asia.

ScinoPharm Taiwan Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.2%
=
Operating Income
NT$165.9m
/
Revenue
NT$3.2B
What is ScinoPharm Taiwan Ltd's current Operating Margin?

The current Operating Margin for ScinoPharm Taiwan Ltd is 5.2%, which is below its 3-year median of 9.7%.

How has Operating Margin changed over time?

Over the last 3 years, ScinoPharm Taiwan Ltd’s Operating Margin has decreased from 11.5% to 5.2%. During this period, it reached a low of 5.2% on Oct 30, 2025 and a high of 12.9% on Jun 30, 2024.

Back to Top